Noopept: Cognitive Peptide-Like Nootropic
Noopept (N-phenylacetyl-L-prolylglycine ethyl ester) is a dipeptide-derived nootropic used in several countries for cognitive impairment and studied for memory, neuroprotection, and antioxidant effects.
A potent peptide-derived nootropic used for cognitive decline in certain regions.
🧠 Memory & Learning
Regional studies show improvements in memory consolidation and recall.
🛡️ Neuroprotection
Shown to reduce oxidative stress and improve neuronal resilience in preclinical models.
⚡ Cognitive Clarity
Users report improved clarity and mental stamina; evidence varies.
What Is Noopept?
Noopept is a synthetic peptide-derived molecule with structural similarity to cyclic dipeptides and racetams. It exerts its effects by:
- Enhancing **BDNF and NGF** expression
- Modulating **glutamate signaling**
- Supporting **antioxidant pathways**
- Improving cerebral blood flow in some models
Evidence & Applications
Noopept has been used in Russia for mild cognitive impairment, post-TBI recovery, and vascular dementia.
- Shown to support memory performance in small human trials
- May improve mood and reduce irritability/anxiety symptoms
- Demonstrates antioxidant and anti-inflammatory properties
Regulatory Status
- Prescription medicine in some Eastern European countries
- Not FDA-approved; sold as a research chemical or supplement in the U.S.
- Quality and dosage vary widely outside regulated pharmacies
Typical Use (Educational Overview)
- Oral tablets or capsules
- Often 20–30 mg/day in regional protocols
- Used in 1–3 month cycles
Safety & Considerations
- Generally well tolerated
- Possible effects: irritability, headaches, insomnia, mild anxiety
- May interact with stimulants or psychiatric medications
Plain-Language Summary
Noopept is a peptide-derived nootropic with real—but modest—clinical evidence for cognitive support. It is more potent than typical racetams, works at tiny doses, and may offer neuroprotective effects. However, regulation and quality control vary greatly by region.